Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-75dct Total loading time: 0 Render date: 2024-06-08T12:55:43.488Z Has data issue: false hasContentIssue false

Chap. 42 - TREATMENT OF TELANGIECTASIA, POIKILODERMA, AND FACE AND LEG VEINS

from PART FOUR - COSMETIC APPLICATIONS OF LIGHT, RADIOFREQUENCY, AND ULTRASOUND ENERGY

Published online by Cambridge University Press:  06 July 2010

Sorin Eremia
Affiliation:
University of California, Los Angeles, School of Medicine
Get access

Summary

Vascular lesions are one of the most common indications for laser therapy. While first and still commonly used for the treatment of port-wine stains and hemangiomas, this chapter will focus on their use for telangiectasias, facial veins, poikiloderma of Civatte, and leg veins. The most frequently used light devices for vascular lesions are the 532-nm potassium titanyl phosphate (KTP) and, more recently, diode laser; the 595-nm pulsed dye laser (PDL); the 1,064-nm Nd:YAG lasers; and the intense pulsed light (IPL) devices. Table 42.1 outlines the various vascular-specific laser and light-based systems. These systems work through selective photothermolysis with oxyhemoglobin (oxy-hb) as the target chromophore in vascular lesions. The absorption peaks for oxy-hb are 418 nm, 542 nm, and 577 nm. By targeting oxy-hb, pulses of energy are transferred to the surrounding vessel wall to selectively heat and destroy the abnormal blood vessels. The success of vascular lasers depends on their wavelength, pulse duration, and spot size as they relate to vessel depth and diameter:

  • The wavelength used needs to have sufficient penetration depth and selectivity for the target vasculature.

  • The pulse duration should be less than thermal relaxation time (TRT) to affect the intended target, while sparing surrounding structures. The TRT is the cooling time of the target and is proportional to the square of the vessel diameter. For example, a vessel 0.03 mm in size has a TRT of 0.86 ms, as compared to a 0.1 mm vessel, which has a 9.6-ms TRT. Longer pulse durations allow for slower heating of the target, which prevents rapid temperature spikes, which cause vessel wall rupture and purpura. When pulse durations exceed the TRT of the target structure, more heat diffuses outside the vessels, leading to unwanted thermal damage to surrounding tissue.

  • […]

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alam, M, Dover, JS, Arndt, KA. Treatment of facial telangiectasia with variable-pulse high-fluence pulsed-dye laser: comparison of efficacy with fluences immediately above and below the purpura threshold. Dermatol. Surg. 2003;29:681–4; discussion 685.Google ScholarPubMed
Baumler, W, Ulrich, H, Hartl, A, Landthaler, M, Shafirstein, G. Optimal parameters for the treatment of leg veins using Nd:YAG lasers at 1064 nm. Br. J. Dermatol. 2006;155:364–71.CrossRefGoogle ScholarPubMed
Bernstein, EF, Lee, J, Lowery, J, et al. Treatment of spider veins with the 595 nm pulsed dye laser. J. Am. Acad. Dermatol. 1998;39:746–50.CrossRefGoogle ScholarPubMed
Goldman, MP. Optimal management of facial telangiectasia. Am. J. Clin. Dermatol. 2004;5:423–34.CrossRefGoogle ScholarPubMed
Ross, EV, Smirnov, M, Pankratov, M, Altshuler, G. Intense pulsed light and laser treatment of facial telangiectasias and dyspigmentation: some theoretical and practical comparisons. Dermatol. Surg. 2005;31(9 Pt 2):1188–98.CrossRefGoogle ScholarPubMed
Sadick, NS. Laser and intense pulsed light therapy for the esthetic treatment of lower extremity veins. Am. J. Clin. Dermatol. 2003;4:545–54. Review.CrossRefGoogle ScholarPubMed
Tanghetti, E, Sherr, E. Treatment of telangiectasia using the multi-pass technique with the extended pulse width, pulsed dye laser (Cynosure V-Star). J. Cosmet. Laser Ther. 2003;5:71–5.CrossRefGoogle Scholar
Uebelhoer, NS, Bogle, MA, Stewart, B, Arndt, KA, Dover, JS. A split-face comparison study of pulsed 532-nm KTP laser and 595-nm pulsed dye laser in the treatment of facial telangiectasias and diffuse telangiectatic facial erythema. Dermatol. Surg. 2007;33:441–8.Google ScholarPubMed
Weiss, RA, Goldman, MP, Weiss, MA. Treatment of poikiloderma of Civatte with an intense pulsed light source. Dermatol. Surg. 2000;26:823–7; discussion 828.CrossRefGoogle ScholarPubMed
West, TB, Alster, TS. Comparison of the long-pulse dye (590–595 nm) and KTP (532 nm) lasers in the treatment of facial and leg telangiectasias. Dermatol. Surg. 1998;24:221–6.CrossRefGoogle ScholarPubMed
Woo, SH, Ahn, HH, Kim, SN, Kye, YC. Treatment of vascular skin lesions with the variable-pulse 595 nm pulsed dye laser. Dermatol. Surg. 2006;32:41–8.CrossRefGoogle ScholarPubMed
Ceulen, RP, Bullens-Goessens, YI, Pi-Van, , et al. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: results of a randomized controlled trial with 1-year follow-up. Dermatol. Surg. 2007;33:276–81.Google ScholarPubMed
Dover, JS, Sadick, NS, Goldman, MP. The role of lasers and light sources in the treatment of leg veins. Dermatol. Surg. 1999;25:328–36.Google ScholarPubMed
Frullini, A, Cavezzi, A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol. Surg. 2002;28:11–15.Google ScholarPubMed
Goldman, MP, Weiss, RA. Treatment of leg telangiectasias with laser and high-intense pulsed light. Dermatol. Ther. 2000;13:28–49.CrossRefGoogle Scholar
Guex, JJ, Allaert, FA, Gillet, JL, Chleir, F. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173. Dermatol. Surg. 2005;31:123–8.CrossRefGoogle ScholarPubMed
Huang, Y, Jiang, M, Li, W, Lu, X, Huang, X, Lu, M. Endovenous laser treatment combined with a surgical strategy for treatment of venous insufficiency in lower extremity: a report of 208 cases. J. Vasc. Surg. 2005;42:494–501.CrossRefGoogle ScholarPubMed
Kauvar, ANB. The role of lasers in the treatment of leg veins. Semin. Cutan. Med. Surg. 2000;19:245–52.CrossRefGoogle ScholarPubMed
Leach, BC, Goldman, MP. Comparative trial between sodium tetradecyl sulfate and glycerin in the treatment of telangiectatic leg veins. Dermatol. Surg. 2003;29:612–14.Google ScholarPubMed
Lupton, JR, Alster, TS, Romero, P. Clinical comparison of sclerotherapy versus long-pulsed Nd:YAG laser treatment for lower extremity telangiectases. Dermatol. Surg. 2002;28:694–7.Google ScholarPubMed
Omura, N, Dover, J, Arndt, K, Kauvar, A. Treatment of reticular leg veins with a 1064 nm Nd:YAG. J. Am. Acad. Dermatol. 2003;48:76–81.CrossRefGoogle Scholar
Puggioni, A, Kalra, M, Carmo, M, Mozes, G, Gloviczki, P. Endovenous laser therapy and radiofrequency ablation of the great saphenous vein: analysis of early efficacy and complications. J. Vasc. Surg. 2005;42:488–93.CrossRefGoogle ScholarPubMed
Rao, J, Wildemore, JK, Goldman, MP. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol. Surg. 2005;31:631–5; discussion 635.CrossRefGoogle ScholarPubMed
Sadick, NS. Advances in the treatment of varicose veins: ambulatory phlebectomy, foam sclerotherapy, endovascular laser, and radiofrequency closure. Dermatol. Clin. 2005;23:443–55.CrossRefGoogle ScholarPubMed
Sadick, NS, Wasser, S. Combined endovascular laser plus ambulatory phlebectomy for the treatment of superficial venous incompetence: a 4-year perspective. J. Cosmet. Laser Ther. 2007;9:9–13.CrossRefGoogle ScholarPubMed
Weiss, RA.Endovenous techniques for elimination of saphenous reflux: a valuable treatment modality. Dermatol. Surg. 2001;27:902–5.Google ScholarPubMed
Weiss, RA, Dover, JS. Leg vein management: sclerotherapy, ambulatory phlebectomy, and laser surgery. Semin. Cutan. Med. Surg. 2002;21:76–103.CrossRefGoogle ScholarPubMed
Weiss, RA, Sadick, NS, Goldman, MP, Weiss, MA. Post-sclero- therapy compression: controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol. Surg. 1999;25:105–8.CrossRefGoogle ScholarPubMed
Yamaki, T, Nozaki, M, Iwasaka, S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclero-therapy for the treatment of superficial venous insufficiency. Dermatol. Surg. 2004;30:718–22.Google Scholar
Alam, M, Dover, JS, Arndt, KA. Treatment of facial telangiectasia with variable-pulse high-fluence pulsed-dye laser: comparison of efficacy with fluences immediately above and below the purpura threshold. Dermatol. Surg. 2003;29:681–4; discussion 685.Google ScholarPubMed
Baumler, W, Ulrich, H, Hartl, A, Landthaler, M, Shafirstein, G. Optimal parameters for the treatment of leg veins using Nd:YAG lasers at 1064 nm. Br. J. Dermatol. 2006;155:364–71.CrossRefGoogle ScholarPubMed
Bernstein, EF, Lee, J, Lowery, J, et al. Treatment of spider veins with the 595 nm pulsed dye laser. J. Am. Acad. Dermatol. 1998;39:746–50.CrossRefGoogle ScholarPubMed
Goldman, MP. Optimal management of facial telangiectasia. Am. J. Clin. Dermatol. 2004;5:423–34.CrossRefGoogle ScholarPubMed
Ross, EV, Smirnov, M, Pankratov, M, Altshuler, G. Intense pulsed light and laser treatment of facial telangiectasias and dyspigmentation: some theoretical and practical comparisons. Dermatol. Surg. 2005;31(9 Pt 2):1188–98.CrossRefGoogle ScholarPubMed
Sadick, NS. Laser and intense pulsed light therapy for the esthetic treatment of lower extremity veins. Am. J. Clin. Dermatol. 2003;4:545–54. Review.CrossRefGoogle ScholarPubMed
Tanghetti, E, Sherr, E. Treatment of telangiectasia using the multi-pass technique with the extended pulse width, pulsed dye laser (Cynosure V-Star). J. Cosmet. Laser Ther. 2003;5:71–5.CrossRefGoogle Scholar
Uebelhoer, NS, Bogle, MA, Stewart, B, Arndt, KA, Dover, JS. A split-face comparison study of pulsed 532-nm KTP laser and 595-nm pulsed dye laser in the treatment of facial telangiectasias and diffuse telangiectatic facial erythema. Dermatol. Surg. 2007;33:441–8.Google ScholarPubMed
Weiss, RA, Goldman, MP, Weiss, MA. Treatment of poikiloderma of Civatte with an intense pulsed light source. Dermatol. Surg. 2000;26:823–7; discussion 828.CrossRefGoogle ScholarPubMed
West, TB, Alster, TS. Comparison of the long-pulse dye (590–595 nm) and KTP (532 nm) lasers in the treatment of facial and leg telangiectasias. Dermatol. Surg. 1998;24:221–6.CrossRefGoogle ScholarPubMed
Woo, SH, Ahn, HH, Kim, SN, Kye, YC. Treatment of vascular skin lesions with the variable-pulse 595 nm pulsed dye laser. Dermatol. Surg. 2006;32:41–8.CrossRefGoogle ScholarPubMed
Ceulen, RP, Bullens-Goessens, YI, Pi-Van, , et al. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: results of a randomized controlled trial with 1-year follow-up. Dermatol. Surg. 2007;33:276–81.Google ScholarPubMed
Dover, JS, Sadick, NS, Goldman, MP. The role of lasers and light sources in the treatment of leg veins. Dermatol. Surg. 1999;25:328–36.Google ScholarPubMed
Frullini, A, Cavezzi, A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol. Surg. 2002;28:11–15.Google ScholarPubMed
Goldman, MP, Weiss, RA. Treatment of leg telangiectasias with laser and high-intense pulsed light. Dermatol. Ther. 2000;13:28–49.CrossRefGoogle Scholar
Guex, JJ, Allaert, FA, Gillet, JL, Chleir, F. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173. Dermatol. Surg. 2005;31:123–8.CrossRefGoogle ScholarPubMed
Huang, Y, Jiang, M, Li, W, Lu, X, Huang, X, Lu, M. Endovenous laser treatment combined with a surgical strategy for treatment of venous insufficiency in lower extremity: a report of 208 cases. J. Vasc. Surg. 2005;42:494–501.CrossRefGoogle ScholarPubMed
Kauvar, ANB. The role of lasers in the treatment of leg veins. Semin. Cutan. Med. Surg. 2000;19:245–52.CrossRefGoogle ScholarPubMed
Leach, BC, Goldman, MP. Comparative trial between sodium tetradecyl sulfate and glycerin in the treatment of telangiectatic leg veins. Dermatol. Surg. 2003;29:612–14.Google ScholarPubMed
Lupton, JR, Alster, TS, Romero, P. Clinical comparison of sclerotherapy versus long-pulsed Nd:YAG laser treatment for lower extremity telangiectases. Dermatol. Surg. 2002;28:694–7.Google ScholarPubMed
Omura, N, Dover, J, Arndt, K, Kauvar, A. Treatment of reticular leg veins with a 1064 nm Nd:YAG. J. Am. Acad. Dermatol. 2003;48:76–81.CrossRefGoogle Scholar
Puggioni, A, Kalra, M, Carmo, M, Mozes, G, Gloviczki, P. Endovenous laser therapy and radiofrequency ablation of the great saphenous vein: analysis of early efficacy and complications. J. Vasc. Surg. 2005;42:488–93.CrossRefGoogle ScholarPubMed
Rao, J, Wildemore, JK, Goldman, MP. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol. Surg. 2005;31:631–5; discussion 635.CrossRefGoogle ScholarPubMed
Sadick, NS. Advances in the treatment of varicose veins: ambulatory phlebectomy, foam sclerotherapy, endovascular laser, and radiofrequency closure. Dermatol. Clin. 2005;23:443–55.CrossRefGoogle ScholarPubMed
Sadick, NS, Wasser, S. Combined endovascular laser plus ambulatory phlebectomy for the treatment of superficial venous incompetence: a 4-year perspective. J. Cosmet. Laser Ther. 2007;9:9–13.CrossRefGoogle ScholarPubMed
Weiss, RA.Endovenous techniques for elimination of saphenous reflux: a valuable treatment modality. Dermatol. Surg. 2001;27:902–5.Google ScholarPubMed
Weiss, RA, Dover, JS. Leg vein management: sclerotherapy, ambulatory phlebectomy, and laser surgery. Semin. Cutan. Med. Surg. 2002;21:76–103.CrossRefGoogle ScholarPubMed
Weiss, RA, Sadick, NS, Goldman, MP, Weiss, MA. Post-sclero- therapy compression: controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol. Surg. 1999;25:105–8.CrossRefGoogle ScholarPubMed
Yamaki, T, Nozaki, M, Iwasaka, S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclero-therapy for the treatment of superficial venous insufficiency. Dermatol. Surg. 2004;30:718–22.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×